InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: FairviewInvestor post# 1258

Friday, 05/09/2014 9:03:26 AM

Friday, May 09, 2014 9:03:26 AM

Post# of 1569
Biotechnology Value Fund acquires 6% Passive Stake in Cytokinetics.

http://www.theflyonthewall.com/permalinks/entry.php/CYTKid2008668/CYTK-Biotechnology-Value-Fund-reports--passive-stake-in-Cytokinetics

As I've stated before the accumulation of cheap shares continues. It's only a matter of time before the upgrades occur.

Company has $100M in cash on hand plus the potential for $1B in milestone payments from Amgen and Astellas.

p.s. Don't miss buying/covering at the bottom.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTK News